1. Home > Latest Topics >

Question 12: Fluoroquinolones for AECB

20 June, 2018

question_12_6


LATEST TOPICS

Navigating antibiotic resistance in community-acquired pneumonia: Insights from Vietnam
29 October, 2024
Optimising antibiotic therapy: Insights on transitioning from intravenous to oral treatment for community-acquired pneumonia
27 September, 2024
Community-acquired pneumonia in Cambodia: Navigating the growing challenge of AMR
30 June, 2024
Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024

RELATED ARTICLES

Fluoroquinolones for UTI treatment in Thailand: A closer look at treatment strategies
28 December, 2023
Lower Respiratory Tract Infections: AECOPD, Aspiration, and Pneumonia in the COVID-19 Era (Chapter 5)
27 December, 2022
Fluoroquinolones for the Management of Skin and Soft Tissue Infections
13 June, 2023
Fluoroquinolones in the management of hospital-acquired pneumonia
20 June, 2023
Combination antibiotic therapy for multidrug-resistant, gram-negative bacteria
17 March, 2022